Michael R. Clay
University of Colorado Anschutz Medical Campus(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Protein Degradation and Inhibitors, Cancer Genomics and Diagnostics, Sarcoma Diagnosis and Treatment
Most-Cited Works
- → A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors(2020)770 cited
- → Orthotopic patient-derived xenografts of paediatric solid tumours(2017)300 cited
- → Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses(2018)164 cited
- → Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum(2022)148 cited
- → MYCN amplification and ATRX mutations are incompatible in neuroblastoma(2020)124 cited
- → MDM2 Amplification in Problematic Lipomatous Tumors(2015)92 cited
- → MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?(2016)88 cited
- → Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma(2017)77 cited
- → An update on the central nervous system manifestations of Li–Fraumeni syndrome(2019)70 cited
- → The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma(2022)70 cited